Product Description
Overall, the Australian dental implant and final abutment market was valued at over $125 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.7% to reach over $151 million.
The full report suite on the Australian market for dental implants and final abutments includes dental implants, final abutments, treatment planning software and surgical guides.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
AUSTRALIA DENTAL IMPLANT MARKET TRENDS
A prevailing trend in the Australian dental implant and final abutment market involves the rise of value segment implants and final abutments, presenting a viable and cost-efficient alternative to premium segment offerings. Products in the value and discount segments have experienced significant advantages, benefiting from the transfer of technologies and manufacturing methods traditionally reserved for premium dental products. Consequently, value and discount segment products are gaining recognition as increasingly ideal substitutes for their premium counterparts.
AUSTRALIA DENTAL IMPLANT MARKET SHARE INSIGHTS
In 2023, Straumann Group emerged as the dominant force in the dental implant and final abutment market, leveraging its brand reputation and a history of top-tier implant development. Historically excelling in the premium segment, Straumann’s comprehensive suite of dental products has fueled success across diverse applications. Its subsidiary, Neodent, has excelled in the value segment, further solidifying Straumann’s leadership. Ongoing mergers and acquisitions reinforce its market position.
Envista, the parent company of Nobel Biocare and Implant Direct, closely rivaled Straumann. As the top player in final abutments and second in dental implants, treatment planning software, and surgical guides, Envista’s strategic differentiation positions it for growth and improved margins. Diversification across all market segments and a revenue boost from implant sales make Envista resilient to economic uncertainties.
BioHorizons, the third major competitor, led in the value implant segment in 2023, albeit with higher pricing. While dominating the value sector, BioHorizons faced challenges in the overall market dominated by premium products. Nevertheless, its premium pricing contributed to a leading revenue share within the value segment.
MARKET SEGMENTATION SUMMARY
- Dental Implants Market – The market analysis is further broken down into segments by:
- Type: Premium, Value, Discount;
- Material: Titanium, Ceramic/Zirconia;
- *Procedure Type: One-stage, two-stage, and Immediate Loading;
- *Shape: Parallel Wall, Tapered;
- *Connection Type: Internal Connection, External Connection, On-Piece;
- *Application: Single-Tooth Application, Multi-Tooth Bridge Partial Arch Securement, Multi-Tooth Bridge Full Arch Securement, Denture Securement.
- Final Abutment Market – The chapter contains the market analysis which is categorized by:
- *Type: Cement-Retained, Screw-Retained, and Denture Retaining.
- Fabrication: Stock, Custom Cast, and CAD/CAM;
- Material: Titanium, Ceramic/Zirconia, Gold;
- Instrument Kit Market
- Treatment Planning Software Market
- Surgical Guide Market
*Segment is analyzed at a unit level only.
Research Scope Summary
Report Attribute | Details |
---|---|
Region | Australia |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2022 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Product Portfolios, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |